

The Canadian Association for Population Therapeutics (CAPT-ACTP) is a not-for-profit, membership-based organization dedicated to advancing population-based research in therapeutic interventions. Our diverse community includes scientists, researchers, policymakers, industry leaders, academic professionals, consultants, and patient representatives who work together to address key challenges in population health, therapeutics, health interventions, and evidence generation in Canada.
One of CAPT’s flagship initiatives is our annual conference, a premier event that brings together government policymakers, academic researchers, industry representatives, consultants, patients, and other key stakeholders. This gathering serves as a vital platform for the open exchange of ideas, collaboration, and knowledge-sharing on critical topics, including drug access, health economics, and the use and effects of medications.
Through our conference and year-round initiatives, CAPT fosters an inclusive and collaborative environment, where members engage in scientific discussions, drive innovation, and contribute to evidence-based policymaking to improve healthcare outcomes for all Canadians.
In the early 1990s, members of Canada’s pharmacoepidemiology community came together to establish an annual conference dedicated to advancing the field. This effort led to the inaugural Canadian Pharmacoepidemiology Forum, held in Toronto in 1993.
Building on this momentum, the Canadian Association for Population Therapeutics (CAPT) was officially introduced at a September 1995 meeting of the International Society for Pharmacoepidemiology (ISPE). A formal announcement followed at the annual Canadian Pharmacoepidemiology Forum in 1996, and by 1996–97, CAPT had held its first general election to appoint its inaugural Board of Directors.
While CAPT was founded with a strong focus on pharmacoepidemiology, its visionary leaders recognized the importance of broader interdisciplinary collaboration. They deliberately chose a name that would support future growth beyond pharmacoepidemiology, encompassing fields such as pharmacoeconomics and other therapeutic interventions.
True to this vision, CAPT has evolved into a dynamic, multidisciplinary community of researchers conducting both epidemiological and economic analyses across academia, government, consulting, and industry. As Canada’s leading voice in population therapeutics, CAPT remains the only national association of its kind, committed to fostering collaboration, enhancing visibility, and advancing key research priorities in the field.
[custom-twitter-feeds num=2]